StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30111% above fair value
$56.30+1.31 (+2.38%)

Close on Nov 17, 2026Market cap $7.34BP/E –Yield –

10x Genomics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for 10x Genomics

10x Genomics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More 10x Genomics figures

See a number that looks wrong?